全文获取类型
收费全文 | 14072篇 |
免费 | 1057篇 |
国内免费 | 44篇 |
专业分类
耳鼻咽喉 | 174篇 |
儿科学 | 455篇 |
妇产科学 | 316篇 |
基础医学 | 1757篇 |
口腔科学 | 149篇 |
临床医学 | 1805篇 |
内科学 | 3189篇 |
皮肤病学 | 456篇 |
神经病学 | 1259篇 |
特种医学 | 524篇 |
外国民族医学 | 7篇 |
外科学 | 1624篇 |
综合类 | 125篇 |
一般理论 | 6篇 |
预防医学 | 1449篇 |
眼科学 | 93篇 |
药学 | 944篇 |
中国医学 | 14篇 |
肿瘤学 | 827篇 |
出版年
2023年 | 82篇 |
2022年 | 79篇 |
2021年 | 263篇 |
2020年 | 155篇 |
2019年 | 261篇 |
2018年 | 334篇 |
2017年 | 258篇 |
2016年 | 279篇 |
2015年 | 340篇 |
2014年 | 429篇 |
2013年 | 615篇 |
2012年 | 884篇 |
2011年 | 914篇 |
2010年 | 461篇 |
2009年 | 433篇 |
2008年 | 824篇 |
2007年 | 810篇 |
2006年 | 900篇 |
2005年 | 874篇 |
2004年 | 811篇 |
2003年 | 776篇 |
2002年 | 712篇 |
2001年 | 247篇 |
2000年 | 228篇 |
1999年 | 233篇 |
1998年 | 165篇 |
1997年 | 124篇 |
1996年 | 130篇 |
1995年 | 106篇 |
1994年 | 92篇 |
1993年 | 79篇 |
1992年 | 181篇 |
1991年 | 163篇 |
1990年 | 143篇 |
1989年 | 155篇 |
1988年 | 108篇 |
1987年 | 146篇 |
1986年 | 114篇 |
1985年 | 125篇 |
1984年 | 102篇 |
1983年 | 81篇 |
1982年 | 57篇 |
1981年 | 77篇 |
1980年 | 58篇 |
1979年 | 89篇 |
1978年 | 58篇 |
1976年 | 56篇 |
1974年 | 72篇 |
1973年 | 63篇 |
1972年 | 54篇 |
排序方式: 共有10000条查询结果,搜索用时 281 毫秒
1.
Breanne E. Kunstler Jill L. Cook Joanne L. Kemp Paul D. O’Halloran Caroline F. Finch 《Journal of Science and Medicine in Sport》2019,22(1):2-10
Objectives
To determine: (i) the behaviour change techniques used by a sample of Australian physiotherapists to promote non-treatment physical activity; and (ii) whether those behaviour change techniques are different to the techniques used to encourage adherence to rehabilitation exercises.Design
Cross-sectional survey.Method
An online self-report survey was advertised to private practice and outpatient physiotherapists treating patients with musculoskeletal conditions. The use of 50 behaviour change techniques were measured using five-point Likert-type scale questions.Results
Four-hundred and eighty-six physiotherapists responded to the survey, with 216 surveys fully completed. Most respondents (85.1%) promoted non-treatment physical activity often or all of the time. Respondents frequently used 29 behaviour change techniques to promote non-treatment physical activity or encourage adherence to rehabilitation exercises. A similar number of behaviour change techniques was frequently used to encourage adherence to rehabilitation exercises (n = 28) and promote non-treatment physical activity (n = 26). Half of the behaviour change techniques included in the survey were frequently used for both promoting non-treatment physical activity and encouraging adherence to rehabilitation exercises (n = 25). Graded tasks was the most, and punishment was the least, frequently reported technique used to promote non-treatment physical activity and encourage adherence to rehabilitation exercises.Conclusions
Respondents reported using similar behaviour change techniques to promote non-treatment physical activity and encourage adherence to rehabilitation exercises. The variability in behaviour change technique use suggests the behaviour the physiotherapist is promoting influences their behaviour change technique choice. Including the frequently-used behaviour change techniques in non-treatment physical activity promotion interventions might improve their efficacy. 相似文献2.
3.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
4.
5.
6.
7.
8.
Fran ois X. Roux M.D. Serge Mordon Ph.D. Catherine Fallet-Bianco M.D. Louis Merienne M.D. Bertrand C. Devaux M.D. Jean-Paul Chodkiewicz M.D. 《Surgical neurology》1990,34(6):402-407
Considering that the 1.32-μm Nd-YAG laser should have physicothermal properties close to those of the CO2 laser, a series of experiments were conducted on rat cortex (N = 51). Three laser wavelengths were compared: CO2 laser (10.6 μm), 1.06-μm Nd-YAG, and 1.32-μm Nd-YAG lasers. For each shot, temperature measurements were recorded with an infrared thermographic videocamera. The digitized signals were figured as thermal profiles and temperature developments. Ninety-five shots were correctly studied and analyzed: CO2, N = 29; 1.06-μm Nd-YAG, N = 20; 1.32-μm Nd-YAG, N = 46. The histological lesions produced by these three lasers were compared on animals killed 24 hours (N = 20), 8 days (N = 20), and 30 days (N = 5) after the laser impacts. For equivalent densities of energy, the depth of cortical necrosis was comparable for the CO2 laser (200–250 μm) and the 1.32-μm Nd-YAG laser (210–260μm) whatever the date of death; the 1.06-μm Nd-YAG laser shots were responsible for much more important damage (400–550μm). Because of its important absorption in water and nervous tissue, the authors consider the 1.32-μm Nd-YAG laser most suitable for neurosurgery, particularly because it is conducted through optic fibers, and therefore is easy to handle during neurosurgical procedures. 相似文献
9.
Several studies have demonstrated that a descending dopaminergic pathway innervates the dorsal and the intermediate gray matter of the spinal cord and have suggested that this pathway is involved in pain modulation and in the control of autonomie functions. Other studies have also demonstrated the presence of dopamine (DA) and DA metabolites as well as of DA receptors in the ventral cord. There is also evidence for the implication of DA in the control of motor functions at the spinal level. The occurrence of a dopaminergic innervation in the ventral horn has been, however, disputed until recently. But recent work has demonstrated that the motoneural cell groups in the ventral horn (lamina IX) are a target for descending dopaminergic fibers. In addition, the possibility that DA is a mediator of primary afferent fibers has also been postulated. Finally, the occurrence of dopaminergic cell bodies has been suggested in the spinal cord. This indicates that DA is probably implicated in a complex manner in spinal functions. In the present paper the possible involvement of DA in sensory and in motor functions at spinal level will be discussed in view of neurochemical observations made in polyarthritic rats, in which pain-related behavior and reduction of locomotor activity associated with a marked decrease in mobility, are observed. 相似文献
10.